1. P162 Prevalence and incidence of nonalcoholic fatty liver disease in Inflammatory Bowel Disease patients: risk factors for progression. (21st January 2022) Authors: Crispino, F; Brinch, D; Scrivo, B; Celsa, C; Di Grado, G; Sapia, A; Petta, S; Cappello, M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P162 Prevalence of nafld (non alcoholic fatty liver disease) and fibrosis in inflammatory bowel disease: the impact of traditional risk factors, intestinal inflammation and genetic phenotype. (15th January 2020) Authors: Scrivo, B; Celsa, C; Busacca, A; Giuffrida, E; Pipitone, R M; Grimaudo, S; Calogero, C; Petta, S; Cappello, M Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P178 Remote monitoring as an effective management strategy in inflammatory bowel disease: the lesson from COVID-19 pandemic. (27th May 2021) Authors: Busacca, A; Sinagra, E; Guida, L; Carrozza, L; Melodia, M; Maida, M; Battaglia, S; Celsa, C; Cammà, C; Cappello, M Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P760 Adalimumab biosimilars versus Azathioprine: indirect comparison of efficacy, safety and persistence in treatment. (30th January 2023) Authors: Saladino, M; Celsa, C; Amato, L M; Di Giorgio, F M; Muscarella, S; Melatti, P; Brinch, D; Cappello, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i891 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗